Jacob Friedman
Concepts (465)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 37 | 2024 | 3131 | 4.350 |
Why?
| | Diabetes, Gestational | 19 | 2023 | 307 | 3.670 |
Why?
| | Non-alcoholic Fatty Liver Disease | 11 | 2023 | 265 | 2.890 |
Why?
| | Maternal Nutritional Physiological Phenomena | 14 | 2025 | 178 | 2.890 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 11 | 2018 | 33 | 2.850 |
Why?
| | Prenatal Exposure Delayed Effects | 16 | 2025 | 665 | 2.620 |
Why?
| | Fatty Liver | 12 | 2014 | 252 | 2.530 |
Why?
| | Adiposity | 15 | 2024 | 533 | 2.210 |
Why?
| | Liver | 25 | 2025 | 1864 | 2.120 |
Why?
| | Pregnancy | 65 | 2025 | 7230 | 1.820 |
Why?
| | Muscle, Skeletal | 15 | 2020 | 1818 | 1.630 |
Why?
| | Diet, Western | 9 | 2025 | 89 | 1.410 |
Why?
| | Diet, High-Fat | 8 | 2022 | 267 | 1.340 |
Why?
| | Insulin Resistance | 15 | 2023 | 1247 | 1.200 |
Why?
| | Fetus | 11 | 2024 | 800 | 1.180 |
Why?
| | Fatty Acids | 5 | 2017 | 460 | 1.180 |
Why?
| | Gastrointestinal Microbiome | 5 | 2024 | 769 | 1.150 |
Why?
| | Insulin | 26 | 2022 | 2525 | 1.140 |
Why?
| | Pregnancy Complications | 8 | 2024 | 609 | 1.110 |
Why?
| | Adipogenesis | 4 | 2017 | 56 | 1.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2017 | 55 | 1.090 |
Why?
| | Bone Marrow | 2 | 2023 | 310 | 1.090 |
Why?
| | Birth Weight | 7 | 2020 | 521 | 1.050 |
Why?
| | Lipid Metabolism | 14 | 2023 | 533 | 0.990 |
Why?
| | Fetal Development | 5 | 2018 | 297 | 0.940 |
Why?
| | Epigenesis, Genetic | 5 | 2016 | 712 | 0.860 |
Why?
| | Glucose | 12 | 2023 | 1053 | 0.860 |
Why?
| | Oxidative Stress | 9 | 2022 | 1369 | 0.860 |
Why?
| | Microbiota | 4 | 2022 | 725 | 0.830 |
Why?
| | DNA Methylation | 6 | 2023 | 725 | 0.820 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2023 | 193 | 0.810 |
Why?
| | Fetal Growth Retardation | 8 | 2019 | 592 | 0.790 |
Why?
| | Inflammation | 10 | 2018 | 2919 | 0.760 |
Why?
| | Animals | 55 | 2025 | 38107 | 0.760 |
Why?
| | Sirtuin 3 | 3 | 2013 | 60 | 0.760 |
Why?
| | Dietary Fats | 4 | 2017 | 307 | 0.760 |
Why?
| | Mitochondria | 8 | 2024 | 997 | 0.750 |
Why?
| | PPAR gamma | 5 | 2017 | 182 | 0.730 |
Why?
| | Female | 75 | 2025 | 79499 | 0.710 |
Why?
| | Umbilical Cord | 3 | 2017 | 92 | 0.700 |
Why?
| | Macrophages | 7 | 2024 | 1532 | 0.690 |
Why?
| | Energy Metabolism | 8 | 2019 | 930 | 0.690 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2012 | 29 | 0.660 |
Why?
| | Gluconeogenesis | 8 | 2018 | 81 | 0.660 |
Why?
| | Breast Feeding | 3 | 2020 | 447 | 0.650 |
Why?
| | Fatty Acids, Omega-3 | 3 | 2022 | 145 | 0.630 |
Why?
| | Infant Formula | 1 | 2020 | 71 | 0.620 |
Why?
| | Infant, Newborn | 18 | 2024 | 6460 | 0.620 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 102 | 0.610 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 32 | 0.600 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 432 | 0.590 |
Why?
| | Transgenes | 1 | 2020 | 178 | 0.580 |
Why?
| | Maternal Exposure | 2 | 2021 | 189 | 0.580 |
Why?
| | Gene Expression Regulation | 10 | 2019 | 2599 | 0.580 |
Why?
| | Blood Glucose | 13 | 2024 | 2360 | 0.560 |
Why?
| | Amino Acids | 4 | 2017 | 515 | 0.550 |
Why?
| | PQQ Cofactor | 2 | 2022 | 5 | 0.550 |
Why?
| | Endoplasmic Reticulum | 3 | 2010 | 268 | 0.540 |
Why?
| | Mothers | 6 | 2018 | 772 | 0.530 |
Why?
| | Macrophage Activation | 3 | 2014 | 182 | 0.520 |
Why?
| | Muscle Proteins | 2 | 2014 | 242 | 0.520 |
Why?
| | Diet | 6 | 2024 | 1273 | 0.520 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 209 | 0.510 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 47 | 0.510 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2012 | 384 | 0.510 |
Why?
| | Triglycerides | 8 | 2023 | 527 | 0.500 |
Why?
| | Adenylate Kinase | 3 | 2014 | 26 | 0.500 |
Why?
| | Metabolic Diseases | 2 | 2017 | 114 | 0.490 |
Why?
| | Hyperlipidemias | 2 | 2016 | 120 | 0.480 |
Why?
| | Mice | 22 | 2024 | 18297 | 0.480 |
Why?
| | Pediatric Obesity | 3 | 2022 | 635 | 0.480 |
Why?
| | Adipose Tissue | 6 | 2018 | 642 | 0.470 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 84 | 0.450 |
Why?
| | Niacinamide | 1 | 2016 | 103 | 0.450 |
Why?
| | Insulin Receptor Substrate Proteins | 5 | 2011 | 55 | 0.440 |
Why?
| | Postprandial Period | 4 | 2024 | 114 | 0.430 |
Why?
| | Humans | 59 | 2024 | 146342 | 0.430 |
Why?
| | Gene Expression | 3 | 2017 | 1463 | 0.430 |
Why?
| | Mitochondrial Proteins | 2 | 2014 | 263 | 0.430 |
Why?
| | Antioxidants | 2 | 2023 | 544 | 0.420 |
Why?
| | Fenofibrate | 2 | 2016 | 28 | 0.410 |
Why?
| | Cholesterol | 1 | 2016 | 411 | 0.400 |
Why?
| | Metabolomics | 3 | 2017 | 738 | 0.400 |
Why?
| | Infant | 11 | 2022 | 10114 | 0.400 |
Why?
| | beta Catenin | 1 | 2015 | 250 | 0.390 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 27 | 0.390 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2010 | 14 | 0.390 |
Why?
| | Hepacivirus | 2 | 2012 | 237 | 0.390 |
Why?
| | Macaca | 4 | 2018 | 66 | 0.380 |
Why?
| | Placenta | 5 | 2021 | 794 | 0.380 |
Why?
| | Orphan Nuclear Receptors | 1 | 2012 | 14 | 0.380 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2012 | 8 | 0.380 |
Why?
| | Glucose Tolerance Test | 7 | 2018 | 360 | 0.370 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.360 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 902 | 0.360 |
Why?
| | Calcium Signaling | 1 | 2014 | 246 | 0.360 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 70 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2022 | 2623 | 0.360 |
Why?
| | Viral Nonstructural Proteins | 1 | 2012 | 64 | 0.350 |
Why?
| | Atherosclerosis | 1 | 2016 | 410 | 0.350 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 60 | 0.350 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2010 | 370 | 0.340 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 307 | 0.340 |
Why?
| | Liver Cirrhosis | 2 | 2025 | 278 | 0.330 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 36 | 0.330 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 156 | 0.330 |
Why?
| | MicroRNAs | 2 | 2020 | 699 | 0.330 |
Why?
| | Bile Acids and Salts | 2 | 2025 | 163 | 0.320 |
Why?
| | Sheep | 8 | 2023 | 870 | 0.320 |
Why?
| | Hypoxia | 1 | 2018 | 1211 | 0.320 |
Why?
| | Genome, Viral | 1 | 2012 | 217 | 0.320 |
Why?
| | Primates | 4 | 2024 | 133 | 0.310 |
Why?
| | Metformin | 3 | 2023 | 328 | 0.300 |
Why?
| | Signal Transduction | 12 | 2020 | 5246 | 0.300 |
Why?
| | RNA, Messenger | 7 | 2017 | 2791 | 0.300 |
Why?
| | Pre-Eclampsia | 1 | 2012 | 206 | 0.300 |
Why?
| | Phosphorylation | 8 | 2021 | 1724 | 0.300 |
Why?
| | Glucose Intolerance | 1 | 2011 | 142 | 0.300 |
Why?
| | Phenylbutyrates | 1 | 2009 | 23 | 0.290 |
Why?
| | Receptors, Adiponectin | 1 | 2009 | 23 | 0.290 |
Why?
| | Male | 26 | 2025 | 73396 | 0.290 |
Why?
| | Hyperglycemia | 2 | 2020 | 384 | 0.280 |
Why?
| | Sulfonamides | 1 | 2012 | 594 | 0.280 |
Why?
| | Lactation | 3 | 2024 | 193 | 0.270 |
Why?
| | Lipids | 5 | 2017 | 714 | 0.270 |
Why?
| | Up-Regulation | 2 | 2010 | 841 | 0.270 |
Why?
| | Adult | 24 | 2024 | 41087 | 0.270 |
Why?
| | Body Mass Index | 8 | 2022 | 2458 | 0.260 |
Why?
| | Dietary Supplements | 5 | 2022 | 587 | 0.260 |
Why?
| | Immunity, Innate | 2 | 2024 | 844 | 0.260 |
Why?
| | Diet, Fat-Restricted | 3 | 2023 | 79 | 0.260 |
Why?
| | Biomarkers | 8 | 2023 | 4340 | 0.250 |
Why?
| | Haplorhini | 2 | 2018 | 51 | 0.250 |
Why?
| | Liver Neoplasms | 2 | 2010 | 776 | 0.250 |
Why?
| | Lipoprotein Lipase | 3 | 2018 | 55 | 0.240 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 71 | 0.240 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 6034 | 0.240 |
Why?
| | Preconception Care | 2 | 2018 | 50 | 0.230 |
Why?
| | Electron Transport | 2 | 2017 | 110 | 0.230 |
Why?
| | Carnitine | 2 | 2017 | 91 | 0.230 |
Why?
| | Muscle Development | 2 | 2017 | 114 | 0.230 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1224 | 0.230 |
Why?
| | Diabetes Mellitus | 2 | 2007 | 1101 | 0.230 |
Why?
| | Oxidation-Reduction | 4 | 2017 | 1075 | 0.230 |
Why?
| | Blotting, Western | 6 | 2019 | 1177 | 0.220 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 3 | 2012 | 146 | 0.220 |
Why?
| | Glucose Clamp Technique | 4 | 2019 | 199 | 0.220 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 153 | 0.220 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 154 | 0.220 |
Why?
| | Enzyme Activation | 3 | 2012 | 759 | 0.220 |
Why?
| | Cytokines | 6 | 2018 | 2081 | 0.220 |
Why?
| | Milk, Human | 2 | 2020 | 176 | 0.220 |
Why?
| | Phosphoproteins | 4 | 2006 | 320 | 0.210 |
Why?
| | Diet, Diabetic | 2 | 2015 | 33 | 0.210 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2018 | 39 | 0.210 |
Why?
| | Hepatocytes | 3 | 2023 | 224 | 0.200 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2025 | 213 | 0.200 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2024 | 61 | 0.200 |
Why?
| | Glucokinase | 1 | 2003 | 15 | 0.200 |
Why?
| | Prolactin | 1 | 2003 | 88 | 0.190 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2003 | 53 | 0.190 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 167 | 0.190 |
Why?
| | Postpartum Period | 4 | 2020 | 377 | 0.190 |
Why?
| | Cyclic AMP | 1 | 2003 | 208 | 0.190 |
Why?
| | Tryptophan | 1 | 2024 | 184 | 0.190 |
Why?
| | Cell Line, Tumor | 5 | 2014 | 3545 | 0.180 |
Why?
| | Mice, Knockout | 6 | 2014 | 3125 | 0.180 |
Why?
| | Bifidobacterium | 1 | 2022 | 21 | 0.180 |
Why?
| | Glycerol | 1 | 2022 | 90 | 0.180 |
Why?
| | Progesterone | 1 | 2003 | 214 | 0.180 |
Why?
| | Leukocytes | 1 | 2024 | 301 | 0.180 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2134 | 0.170 |
Why?
| | Insulins | 1 | 2022 | 39 | 0.170 |
Why?
| | Forkhead Transcription Factors | 2 | 2012 | 209 | 0.170 |
Why?
| | Dexamethasone | 1 | 2003 | 368 | 0.170 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.160 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.160 |
Why?
| | Cell Differentiation | 4 | 2017 | 1982 | 0.160 |
Why?
| | Longitudinal Studies | 3 | 2020 | 3017 | 0.160 |
Why?
| | Response Elements | 2 | 2011 | 85 | 0.160 |
Why?
| | Thapsigargin | 2 | 2010 | 20 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2019 | 974 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 263 | 0.150 |
Why?
| | Insulin-Secreting Cells | 1 | 2024 | 393 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2002 | 315 | 0.150 |
Why?
| | Child | 9 | 2023 | 22693 | 0.150 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 49 | 0.150 |
Why?
| | Gestational Age | 6 | 2019 | 990 | 0.150 |
Why?
| | Immune System | 1 | 2020 | 181 | 0.150 |
Why?
| | Body Composition | 5 | 2017 | 689 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 444 | 0.140 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 112 | 0.140 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.140 |
Why?
| | Risk Factors | 6 | 2022 | 10921 | 0.140 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 58 | 0.140 |
Why?
| | Phenotype | 4 | 2023 | 3206 | 0.140 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1242 | 0.140 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4580 | 0.140 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 320 | 0.140 |
Why?
| | PPAR alpha | 3 | 2022 | 56 | 0.140 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 61 | 0.140 |
Why?
| | Transcription Factors | 2 | 2007 | 1730 | 0.140 |
Why?
| | Fetal Macrosomia | 1 | 2018 | 64 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1792 | 0.130 |
Why?
| | Micronutrients | 1 | 2018 | 102 | 0.130 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.130 |
Why?
| | Rats | 4 | 2012 | 5586 | 0.130 |
Why?
| | Niacin | 1 | 2017 | 16 | 0.130 |
Why?
| | Muscle Cells | 1 | 2017 | 41 | 0.130 |
Why?
| | Islets of Langerhans | 1 | 2003 | 852 | 0.120 |
Why?
| | Interleukin-10 | 2 | 2024 | 310 | 0.120 |
Why?
| | Dysbiosis | 1 | 2018 | 184 | 0.120 |
Why?
| | Bone Marrow Cells | 2 | 2016 | 328 | 0.120 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 94 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2020 | 441 | 0.120 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 162 | 0.120 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 330 | 0.120 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.120 |
Why?
| | Sirtuin 1 | 1 | 2016 | 35 | 0.120 |
Why?
| | Foam Cells | 1 | 2016 | 17 | 0.120 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.120 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.120 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 166 | 0.120 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 51 | 0.120 |
Why?
| | Ceramides | 1 | 2016 | 114 | 0.120 |
Why?
| | Gene Deletion | 2 | 2018 | 385 | 0.110 |
Why?
| | Computational Biology | 1 | 2020 | 678 | 0.110 |
Why?
| | Nutritional Status | 2 | 2018 | 346 | 0.110 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 74 | 0.110 |
Why?
| | Colitis | 1 | 2018 | 283 | 0.110 |
Why?
| | Space Flight | 1 | 2016 | 73 | 0.110 |
Why?
| | Cells, Cultured | 4 | 2016 | 4118 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 415 | 0.110 |
Why?
| | Feces | 1 | 2018 | 496 | 0.110 |
Why?
| | Interleukin-6 | 2 | 2016 | 784 | 0.110 |
Why?
| | Cell Division | 1 | 2017 | 736 | 0.110 |
Why?
| | 3T3-L1 Cells | 2 | 2012 | 36 | 0.110 |
Why?
| | Gene Silencing | 1 | 2016 | 200 | 0.110 |
Why?
| | Glucose-6-Phosphatase | 2 | 2012 | 32 | 0.110 |
Why?
| | Hypoglycemic Agents | 3 | 2018 | 1412 | 0.110 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 216 | 0.110 |
Why?
| | Bacteria | 1 | 2020 | 766 | 0.110 |
Why?
| | Hematopoiesis | 1 | 2016 | 195 | 0.110 |
Why?
| | Cohort Studies | 3 | 2015 | 6077 | 0.110 |
Why?
| | Awards and Prizes | 1 | 2015 | 72 | 0.100 |
Why?
| | Endocrinology | 1 | 2015 | 77 | 0.100 |
Why?
| | Maternal Welfare | 1 | 2014 | 22 | 0.100 |
Why?
| | Glucose Transporter Type 4 | 2 | 2006 | 39 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 352 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 846 | 0.100 |
Why?
| | Animal Feed | 1 | 2014 | 50 | 0.100 |
Why?
| | Carrier Proteins | 2 | 2012 | 728 | 0.100 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 171 | 0.100 |
Why?
| | Nutrition Assessment | 1 | 2014 | 90 | 0.100 |
Why?
| | Body Weight | 4 | 2016 | 968 | 0.100 |
Why?
| | Adolescent | 7 | 2023 | 22557 | 0.100 |
Why?
| | Intestines | 2 | 2013 | 351 | 0.100 |
Why?
| | Dietary Fiber | 1 | 2013 | 59 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1031 | 0.100 |
Why?
| | Sheep, Domestic | 2 | 2019 | 33 | 0.100 |
Why?
| | Dietary Carbohydrates | 1 | 2014 | 146 | 0.100 |
Why?
| | Overweight | 2 | 2015 | 614 | 0.090 |
Why?
| | Liver X Receptors | 1 | 2012 | 29 | 0.090 |
Why?
| | Young Adult | 7 | 2018 | 14330 | 0.090 |
Why?
| | Fasting | 3 | 2018 | 280 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 666 | 0.090 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2012 | 24 | 0.090 |
Why?
| | Enzyme Induction | 1 | 2012 | 87 | 0.090 |
Why?
| | Disease Progression | 1 | 2020 | 2867 | 0.090 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.090 |
Why?
| | Cell Proliferation | 2 | 2017 | 2502 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 75 | 0.090 |
Why?
| | Forkhead Box Protein O1 | 1 | 2012 | 36 | 0.090 |
Why?
| | Adipocytes | 2 | 2017 | 223 | 0.090 |
Why?
| | Lipogenesis | 1 | 2012 | 62 | 0.090 |
Why?
| | Luciferases | 1 | 2012 | 153 | 0.090 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 290 | 0.090 |
Why?
| | Endotoxins | 2 | 2023 | 215 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 1150 | 0.090 |
Why?
| | Transcription Factor RelA | 1 | 2012 | 93 | 0.090 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 201 | 0.090 |
Why?
| | Receptor, Insulin | 4 | 2007 | 92 | 0.090 |
Why?
| | Genes, Reporter | 1 | 2012 | 275 | 0.090 |
Why?
| | Retinoid X Receptor alpha | 1 | 2011 | 4 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 310 | 0.090 |
Why?
| | Glutathione | 1 | 2013 | 369 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 163 | 0.080 |
Why?
| | Random Allocation | 3 | 2023 | 366 | 0.080 |
Why?
| | Fluorocarbons | 1 | 2012 | 122 | 0.080 |
Why?
| | Colorado | 2 | 2020 | 4595 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2017 | 1130 | 0.080 |
Why?
| | Inflammasomes | 1 | 2012 | 145 | 0.080 |
Why?
| | Risk Assessment | 1 | 2020 | 3712 | 0.080 |
Why?
| | Adipocytes, White | 1 | 2010 | 19 | 0.080 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 199 | 0.080 |
Why?
| | NAD | 1 | 2011 | 80 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2012 | 303 | 0.080 |
Why?
| | Tyrosine | 1 | 2011 | 217 | 0.080 |
Why?
| | Serine | 1 | 2011 | 142 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1591 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 266 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.080 |
Why?
| | Proteomics | 2 | 2014 | 1203 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2219 | 0.080 |
Why?
| | Cell Line | 2 | 2007 | 2814 | 0.080 |
Why?
| | Tunicamycin | 1 | 2009 | 11 | 0.070 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2017 | 80 | 0.070 |
Why?
| | Mesoderm | 1 | 2010 | 147 | 0.070 |
Why?
| | Virus Replication | 1 | 2012 | 526 | 0.070 |
Why?
| | Caloric Restriction | 1 | 2011 | 133 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 36 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2010 | 149 | 0.070 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 43 | 0.070 |
Why?
| | CREB-Binding Protein | 1 | 2008 | 34 | 0.070 |
Why?
| | Hypolipidemic Agents | 1 | 2009 | 89 | 0.070 |
Why?
| | Cyclin D1 | 1 | 2008 | 64 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1034 | 0.070 |
Why?
| | Animals, Newborn | 3 | 2017 | 888 | 0.070 |
Why?
| | Time Factors | 3 | 2012 | 7109 | 0.070 |
Why?
| | Wnt Proteins | 1 | 2008 | 131 | 0.070 |
Why?
| | Models, Genetic | 1 | 2010 | 540 | 0.070 |
Why?
| | Placental Insufficiency | 1 | 2009 | 126 | 0.060 |
Why?
| | Prospective Studies | 4 | 2024 | 8123 | 0.060 |
Why?
| | Choline Deficiency | 1 | 2007 | 7 | 0.060 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 37 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 30 | 0.060 |
Why?
| | Child Development | 1 | 2012 | 481 | 0.060 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 29 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 34 | 0.060 |
Why?
| | Palmitates | 1 | 2007 | 21 | 0.060 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 32 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 56 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2022 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2010 | 450 | 0.060 |
Why?
| | Protein Binding | 2 | 2010 | 2244 | 0.060 |
Why?
| | Ribosomal Protein S6 Kinases | 2 | 2008 | 26 | 0.060 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 66 | 0.060 |
Why?
| | Age Factors | 2 | 2011 | 3347 | 0.060 |
Why?
| | Hormones | 1 | 2007 | 134 | 0.060 |
Why?
| | Lipase | 1 | 2007 | 76 | 0.060 |
Why?
| | Fibrosis | 2 | 2023 | 568 | 0.060 |
Why?
| | Histones | 1 | 2012 | 670 | 0.060 |
Why?
| | Methionine | 1 | 2007 | 160 | 0.060 |
Why?
| | Adiponectin | 2 | 2018 | 243 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1022 | 0.060 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 49 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 796 | 0.060 |
Why?
| | Glycemic Index | 2 | 2015 | 26 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2488 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1432 | 0.050 |
Why?
| | Pilot Projects | 2 | 2023 | 1888 | 0.050 |
Why?
| | RNA | 1 | 2011 | 926 | 0.050 |
Why?
| | Insulin Antagonists | 1 | 2003 | 6 | 0.050 |
Why?
| | Keto Acids | 1 | 2003 | 10 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 983 | 0.050 |
Why?
| | NF-kappa B | 1 | 2007 | 674 | 0.050 |
Why?
| | Leptin | 2 | 2018 | 248 | 0.050 |
Why?
| | Drug Synergism | 1 | 2003 | 354 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 324 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1957 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 191 | 0.050 |
Why?
| | Fatty Acid-Binding Protein 7 | 1 | 2002 | 4 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2020 | 455 | 0.040 |
Why?
| | Blotting, Northern | 1 | 2002 | 197 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 288 | 0.040 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2002 | 55 | 0.040 |
Why?
| | Fetal Blood | 1 | 2023 | 325 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2020 | 1763 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 948 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 179 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 227 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3926 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1996 | 0.040 |
Why?
| | Models, Biological | 2 | 2010 | 1761 | 0.040 |
Why?
| | Patient Compliance | 2 | 2014 | 589 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 536 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1041 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2022 | 5439 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 424 | 0.040 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2024 | 704 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 861 | 0.030 |
Why?
| | Cell Membrane | 1 | 2002 | 701 | 0.030 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2022 | 901 | 0.030 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 140 | 0.030 |
Why?
| | Cell Size | 1 | 2017 | 95 | 0.030 |
Why?
| | Protein Biosynthesis | 2 | 2012 | 449 | 0.030 |
Why?
| | Diet Surveys | 1 | 2017 | 89 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 370 | 0.030 |
Why?
| | Guatemala | 1 | 2018 | 349 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1163 | 0.030 |
Why?
| | Lipid Droplets | 1 | 2016 | 24 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 614 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 14 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 613 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2018 | 11821 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 179 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 68 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 82 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11913 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 507 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2014 | 35 | 0.030 |
Why?
| | Health | 1 | 2015 | 81 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 33 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2020 | 1119 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 83 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 294 | 0.020 |
Why?
| | Societies, Medical | 1 | 2018 | 907 | 0.020 |
Why?
| | Dietary Sucrose | 1 | 2013 | 49 | 0.020 |
Why?
| | Prediabetic State | 1 | 2016 | 250 | 0.020 |
Why?
| | Fructose | 1 | 2013 | 132 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2113 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 214 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 1068 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 299 | 0.020 |
Why?
| | Cattle | 1 | 2014 | 940 | 0.020 |
Why?
| | Leucine | 1 | 2012 | 116 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 143 | 0.020 |
Why?
| | Milk | 1 | 2012 | 117 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2011 | 9 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 174 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2014 | 615 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1244 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2011 | 74 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2011 | 55 | 0.020 |
Why?
| | Cell Respiration | 1 | 2011 | 104 | 0.020 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 8 | 0.020 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 34 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 339 | 0.020 |
Why?
| | Pregnancy Outcome | 1 | 2013 | 503 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3647 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 262 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4351 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 704 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 33 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 54 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 377 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 752 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 134 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 16 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 24 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2008 | 115 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 278 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 526 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5899 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 311 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 55 | 0.010 |
Why?
| | Biomedical Research | 1 | 2012 | 729 | 0.010 |
Why?
| | Binding Sites | 1 | 2008 | 1309 | 0.010 |
Why?
| | Organ Size | 1 | 2006 | 465 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3416 | 0.010 |
Why?
| | Fever | 1 | 2006 | 322 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2107 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 457 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 490 | 0.010 |
Why?
| | United States | 1 | 2018 | 16136 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 4093 | 0.010 |
Why?
| | Aged | 1 | 2016 | 26432 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17438 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 36619 | 0.010 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|